Back to Browse Journals » Clinical Ophthalmology » Volume 2 » Issue 1

Clinical treatment options for patients with homonymous visual field defects

Authors Alison R Lane, Daniel T Smith, Thomas Schenk

Published 7 March 2008 Volume 2008:2(1) Pages 93—102


Alison R Lane, Daniel T Smith, Thomas Schenk

Cognitive Neuroscience Research Unit, Durham University, Durham, UK

Abstract: The objective of this review is to evaluate treatments for homonymous visual field defects (HVFDs). We distinguish between three treatments: visual restoration training (VRT), optical aids, and compensatory training. VRT is both the most ambitious and controversial approach, aiming to restore portions of the lost visual field. While early studies suggested that VRT can reduce the visual field defect, recent studies using more reliable means of monitoring the patients’ fixation could not confirm this effect. Studies utilizing modern optical aids have reported some promising results, but the extent to which these aids can reliably reduce the patients’ visual disability has yet to be confirmed. Compensatory approaches, which teach patients more effective ways of using their eyes, are currently the only form of treatment for which behavioral improvements have been demonstrated. However, with the exception of one study using a reading training, placebo-controlled clinical evaluation studies are lacking. It is also not yet clear whether the training benefits found in laboratory tasks lead to reliable improvements in activities of daily living and which of the various forms of compensatory training is the most promising. It is therefore too early to recommend any of the currently available treatment approaches.

Keywords: homonymous hemianopia, rehabilitation, treatment outcome

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

VitalQPlus: a potential screening tool for early diagnosis of COPD

Sui CF, Ming LC, Neoh CF, Ibrahim B

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1613-1622

Published Date: 11 August 2015

Effects of magnetic cobalt ferrite nanoparticles on biological and artificial lipid membranes

Drašler B, Drobne D, Novak S, Valant J, Boljte S, Otrin L, Rappolt M, Sartori B, Iglič A, Kralj-Iglič V, Šuštar V, Makovec D, Gyergyek S, Hočevar M, Godec M, Zupanc J

International Journal of Nanomedicine 2014, 9:1559-1581

Published Date: 27 March 2014

The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes

Tsikripis P, Papaconstantinou D, Koutsandrea C, Apostolopoulos M, Georgalas I

Drug Design, Development and Therapy 2013, 7:1149-1156

Published Date: 4 October 2013

Corneal sensitivity after topical bromfenac sodium eye-drop instillation

Yanai K, Huang J, Kadonosono K, Uchio E

Clinical Ophthalmology 2013, 7:741-744

Published Date: 17 April 2013

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations

Balkundi S, Nowacek AS, Veerubhotla RS, Chen H, Martinez-Skinner A, Roy U, Mosley RL, Kanmogne G, Liu X, Kabanov AV, Bronich T, McMillan J, Gendelman HE

International Journal of Nanomedicine 2011, 6:3393-3404

Published Date: 20 December 2011

Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up

Pia Allegri, Antonio Mastromarino, Piergiorgio Neri

Clinical Ophthalmology 2010, 4:1201-1206

Published Date: 14 October 2010

Correlation between penile cavernosal artery blood flow and retinal vascular findings in arteriogenic erectile dysfunction

Ahmed M Emarah, Shawky M El-Haggar, Ihab A Osman, et al

Clinical Ophthalmology 2010, 4:1047-1051

Published Date: 17 September 2010

Apoptotic and chemotherapeutic properties of iron(III)-salophene in an ovarian cancer animal model

Thilo S Lange, Carolyn McCourt, Rakesh K Singh, Kyu Kwang Kim, Ajay P Singh, et al

Drug Design, Development and Therapy 2009, 3:17-26

Published Date: 17 December 2008